VIROGENOMICS BIODEVELOPMENT, INC.

VIROGENOMICS BIODEVELOPMENT, INC. is a biotech company in Tigard, United States, founded in 2015. It has raised $5.7M across 7 rounds, most recently a $405K Grant in June 2024.

Virogenomics BioDevelopment – Helping you find the full potential of your technology

Headquarters
Tigard, Oregon
Employees
1–10
Founded
2015
Business Model
B2B
Total Funding
$5.7M
Last Round
$405K GrantJun 2024
Rounds
7

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 7 funding rounds for this company. The full record is or through the API.

About

Virogenomics BioDevelopment works with technology leaders at universities and small biotech companies to determine the full potential of early-stage technologies and a path forward that maximizes impact. The company helps bridge the gap between laboratory research and the marketplace by bringing together the scientific, regulatory, and funding pieces necessary for success. Although the firm is relatively new, its executive team and board have focused on early-stage technologies for over a decade. Based in the Pacific Northwest, the team collaborates with partners across the United States.

Summary

It lists 1–10 employees. It has raised $5.7M in total across 7 rounds, most recently a $405K Grant round in Jun 2024.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
GrantSTTR Phase I (NIH)Jun 2024
$405K

Sign up to see all 7 events

Funding: Grant. Amounts, valuations, and investors where available.

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

VIROGENOMICS BIODEVELOPMENT, INC. on Indexed.vc
<a href="https://indexed.vc/companies/virogenomics-biodevelopment-inc"><img src="https://indexed.vc/api/badge/company/virogenomics-biodevelopment-inc" alt="VIROGENOMICS BIODEVELOPMENT, INC. on Indexed.vc" width="260" height="76" /></a>